Oct 22, 2024 8:30am EDT Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
Sep 26, 2024 8:30am EDT Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Sep 23, 2024 8:57am EDT Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
Sep 04, 2024 8:00am EDT Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
Aug 28, 2024 7:10pm EDT Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Aug 13, 2024 4:05pm EDT Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
Jul 11, 2024 8:00am EDT Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
Jun 13, 2024 8:00am EDT Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
May 28, 2024 8:00am EDT Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
May 13, 2024 4:45pm EDT Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results